Cohort Studymoderate evidence

Glucagon-like peptide 1 receptor agonist use and risk of arthroplasty for knee osteoarthritis: retrospective database analysis.

Regional anesthesia and pain medicine·June 2, 2026·PMID 42229941

Why it matters

Knee osteoarthritis lacks effective disease-modifying therapies, and TKA is a major endpoint. These findings suggest GLP-1 RAs may delay or prevent arthroplasty, offering a potential new avenue for OA management beyond weight loss.

Infographic summary of Glucagon-like peptide 1 receptor agonist use and risk of arthroplasty for knee osteoarthritis: retrospective database analysis.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled